{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T06:39:51Z","timestamp":1775975991292,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,9]],"date-time":"2015-04-09T00:00:00Z","timestamp":1428537600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13048-015-0143-5","type":"journal-article","created":{"date-parts":[[2015,4,8]],"date-time":"2015-04-08T04:49:32Z","timestamp":1428468572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["The clinicopathological significance of miR-1307 in chemotherapy resistant epithelial ovarian cancer"],"prefix":"10.1186","volume":"8","author":[{"given":"Yingying","family":"Zhou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianlei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhihui","family":"Jie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Shuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,4,9]]},"reference":[{"key":"143_CR1","doi-asserted-by":"publisher","first-page":"225","DOI":"10.3322\/caac.20006","volume":"59","author":"A Jemal","year":"2009","unstructured":"Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225\u201349.","journal-title":"CA Cancer J Clin"},{"key":"143_CR2","doi-asserted-by":"publisher","first-page":"2519","DOI":"10.1056\/NEJMra041842","volume":"351","author":"SA Cannistra","year":"2004","unstructured":"Cannistra SA. Cancer of the ovary. N Engl J Med. 2004;351:2519\u201329.","journal-title":"N Engl J Med"},{"key":"143_CR3","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1757-2215-4-17","volume":"4","author":"S Kumar","year":"2011","unstructured":"Kumar S, Kumar A, Shah PP, Rai SN, Panguluri SK, Kakar SS. MicroRNA signature of cis-platin resistant vs. cis-platin sensitive ovarian cancer cell lines. J Ovarian Res. 2011;4:17.","journal-title":"J Ovarian Res"},{"key":"143_CR4","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0968-0004(00)89095-7","volume":"20","author":"DB Zamble","year":"1995","unstructured":"Zamble DB, Lippard SJ. Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem Sci. 1995;20:435\u20139.","journal-title":"Trends Biochem Sci"},{"key":"143_CR5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/0092-8674(93)90529-Y","volume":"75","author":"RC Lee","year":"1993","unstructured":"Lee RC, Feinbaum RL, Ambros V. The C.elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14 RNA. Cell. 1993;75:843\u201354.","journal-title":"Cell"},{"key":"143_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","volume":"116","author":"DP Bartel","year":"2004","unstructured":"Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281\u201397.","journal-title":"Cell"},{"key":"143_CR7","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","volume":"6","author":"GA Calin","year":"2006","unstructured":"Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer. 2006;6:857\u201366.","journal-title":"Nat Rev Cancer"},{"key":"143_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1756-8722-5-13","volume":"5","author":"C Labbaye","year":"2012","unstructured":"Labbaye C, Testa U. The emerging role of MIR-146A in the control of hematopoiesis, immune function and cancer. J Hematol Oncol. 2012;5:13.","journal-title":"J Hematol Oncol"},{"key":"143_CR9","doi-asserted-by":"publisher","first-page":"10307","DOI":"10.1158\/0008-5472.CAN-08-1954","volume":"68","author":"N Yang","year":"2008","unstructured":"Yang N, Kaur S, Volinia S, Greshock J, Lassus H, Hasegawa K, et al. MicroRNA microarray identifies Let-7i as a novel biomarker and therapeutic target in human epithelial ovarian cancer. Cancer Res. 2008;68:10307\u201314.","journal-title":"Cancer Res"},{"key":"143_CR10","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1016\/j.ygyno.2008.08.017","volume":"111","author":"A Sorrentino","year":"2008","unstructured":"Sorrentino A, Liu CG, Addario A, Peschle C, Scambia G, Ferlini C. Role of microRNAs in drug-resistant ovarian cancer cells. Gynecol Oncol. 2008;111:478\u201386.","journal-title":"Gynecol Oncol"},{"key":"143_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","volume":"120","author":"BP Lewis","year":"2005","unstructured":"Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell. 2005;120:15\u201320.","journal-title":"Cell"},{"key":"143_CR12","first-page":"1161","volume":"23","author":"DC Corney","year":"2008","unstructured":"Corney DC, Alexander Yu N. MicroRNA and ovarian cancer. Histol Histopathol. 2008;23:1161\u20139.","journal-title":"Histol Histopathol"},{"key":"143_CR13","doi-asserted-by":"publisher","first-page":"13944","DOI":"10.1073\/pnas.0506654102","volume":"102","author":"A1 Cimmino","year":"2005","unstructured":"Cimmino A1, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, et al. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci U S A. 2005;102:13944\u20139.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"143_CR14","doi-asserted-by":"publisher","first-page":"e70300","DOI":"10.1371\/journal.pone.0070300","volume":"8","author":"J Zhang","year":"2013","unstructured":"Zhang J, Lu Y, Yue X, Li H, Luo X, Wang Y, et al. MiR-124 Suppresses Growth of Human Colorectal Cancer by Inhibiting STAT3. PLoS One. 2013;8:e70300.","journal-title":"PLoS One"},{"issue":"1","key":"143_CR15","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1186\/s12967-015-0438-8","volume":"13","author":"XP Mao","year":"2015","unstructured":"Mao XP, Zhang LS, Huang B, Zhou SY, Liao J, Chen LW, et al. Mir-135a enhances cellular proliferation through post-transcriptionally regulating PHLPP2 and FOXO1 in human bladder cancer. J Transl Med. 2015;13(1):438.","journal-title":"J Transl Med"},{"key":"143_CR16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.biopha.2015.01.017","volume":"70","author":"S Zhang","year":"2015","unstructured":"Zhang S, Zhang H, Zhu J, Zhang X, Liu Y. MiR-522 contributes to cell proliferation of human glioblastoma cells by suppressing PHLPP1 expression. Biomed Pharmacother. 2015;70:164\u20139.","journal-title":"Biomed Pharmacother."},{"key":"143_CR17","doi-asserted-by":"crossref","unstructured":"Zhao Z, Zhang L, Yao Q, Tao Z. miR-15b regulates cisplatin resistance and metastasis by targeting PEBP4 in human lung adenocarcinoma cells. Cancer Gene Ther. 2015 Feb 27.","DOI":"10.1038\/cgt.2014.73"},{"key":"143_CR18","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/s13048-014-0084-4","volume":"7","author":"S Chen","year":"2014","unstructured":"Chen S, Chen X, Xiu YL, Sun KX, Zong ZH, Zhao Y. microRNA 490-3P enhances the drug-resistance of human ovarian cancer cells. J Ovarian Res. 2014;7:84.","journal-title":"J Ovarian Res"},{"key":"143_CR19","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.ccr.2007.07.027","volume":"12","author":"GA Calin","year":"2007","unstructured":"Calin GA, Liu CG, Ferracin M, Hyslop T, Spizzo R, Sevignani C, et al. Ultraconserved regions encoding ncRNAs are altered in human leukemias and carcinomas. Cancer Cell. 2007;12:215\u201329.","journal-title":"Cancer Cell"},{"key":"143_CR20","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1002\/ijc.28399","volume":"134","author":"PN Yu","year":"2014","unstructured":"Yu PN, Yan MD, Lai HC, Huang RL, Chou YC, Lin WC, et al. Downregulation of miR-29 contributes to cisplatin resistance of ovarian cancer cells. Int J Cancer. 2014;134:542\u201351.","journal-title":"Int J Cancer"},{"key":"143_CR21","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/bjc.2013.305","volume":"109","author":"JH Huh","year":"2013","unstructured":"Huh JH, Kim TH, Kim K, Song JA, Jung YJ, Jeong JY, et al. Dysregulation of miR-106a and miR-591 confers paclitaxel resistance to ovarian cancer. Br J Cancer. 2013;109:452\u201361.","journal-title":"Br J Cancer"},{"key":"143_CR22","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1158\/1535-7163.MCT-12-0463","volume":"11","author":"DM Cittelly","year":"2012","unstructured":"Cittelly DM, Dimitrova I, Howe EN, Cochrane DR, Jean A, Spoelstra NS, et al. Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel. Mol Cancer Ther. 2012;11:2556\u201365.","journal-title":"Mol Cancer Ther"},{"key":"143_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/1471-2407-13-72","volume":"13","author":"S Prislei","year":"2013","unstructured":"Prislei S, Martinelli E, Mariani M, Raspaglio G, Sieber S, Ferrandina G, et al. MiR-200c and HuR in ovarian cancer. BMC Cancer. 2013;13:72.","journal-title":"BMC Cancer"},{"key":"143_CR24","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1002\/jcb.24488","volume":"114","author":"YQ Wang","year":"2013","unstructured":"Wang YQ, Guo RD, Guo RM, Sheng W, Yin LR. MicroRNA-182 promotes cell growth, invasion and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas. J Cell Biochem. 2013;114:1464\u201373.","journal-title":"J Cell Biochem"},{"key":"143_CR25","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1242\/jcs.072223","volume":"124","author":"G Ye","year":"2011","unstructured":"Ye G, Fu G, Cui S, Zhao S, Bernaudo S, Bai Y, et al. MicroRNA 376c enhances ovarian cancer cell survival by targeting activin receptor-like kinase 7: implications for chemoresistance. J Cell Sci. 2011;124:359\u201368.","journal-title":"J Cell Sci"},{"key":"143_CR26","doi-asserted-by":"publisher","first-page":"4284","DOI":"10.1038\/onc.2012.433","volume":"32","author":"MT1 van Jaarsveld","year":"2013","unstructured":"van Jaarsveld MT1, Helleman J, Boersma AW, van Kuijk PF, van Ijcken WF, Despierre E, et al. miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cells. Oncogene. 2013;32:4284\u201393.","journal-title":"Oncogene"},{"key":"143_CR27","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1038\/onc.2012.575","volume":"33","author":"Y Xiang","year":"2014","unstructured":"Xiang Y, Ma N1, Wang D1, Zhang Y2, Zhou JY, Wu G1, et al. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine. Oncogene. 2014;33:378\u201386.","journal-title":"Oncogene"},{"key":"143_CR28","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1128\/JVI.01689-08","volume":"83","author":"JY Zhu","year":"2009","unstructured":"Zhu JY, Pfuhl T, Motsch N, Barth S, Nicholls J, Gr\u00e4sser F, et al. Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas. J Virol. 2009;83:3333\u201341.","journal-title":"J Virol"},{"key":"143_CR29","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1101\/gr.7179508","volume":"18","author":"RD Morin","year":"2008","unstructured":"Morin RD, O'Connor MD, Griffith M, Kuchenbauer F, Delaney A, Prabhu AL, et al. Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res. 2008;18:610\u201321.","journal-title":"Genome Res"},{"key":"143_CR30","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/path.4003","volume":"227","author":"RD Natrajan","year":"2012","unstructured":"Natrajan RD, Mackay A, Lambros MB, Weigelt B, Wilkerson PM, Manie E, et al. A whole-genome massively parallel sequencing analysis of BRCA1 mutant oestrogen receptor-negative and -positive breast cancers. J Pathol. 2012;227:29\u201341.","journal-title":"J Pathol"},{"key":"143_CR31","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3892\/or.2011.1585","volume":"27","author":"H Shin","year":"2012","unstructured":"Shin H, Lee YS, Lee YC. Sodium butyrate-induced DAPK-mediated apoptosis in human gastric cancer cells. Oncol Rep. 2012;27:1111\u20135.","journal-title":"Oncol Rep"},{"key":"143_CR32","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/j.bbrc.2010.01.054","volume":"392","author":"Y Wu","year":"2010","unstructured":"Wu Y, Yan Q, Zuo J, Saiyin H, Jiang W, Qiao S, et al. Link of Dlk\/ZIP kinase to cell apoptosis and tumor suppression. Biochem Biophys Res Commun. 2010;392:510\u20135.","journal-title":"Biochem Biophys Res Commun"},{"key":"143_CR33","doi-asserted-by":"publisher","first-page":"19170","DOI":"10.1074\/jbc.M110.189829","volume":"286","author":"S Togi","year":"2011","unstructured":"Togi S, Ikeda O, Kamitani S, Nakasuji M, Sekine Y, Muromoto R, et al. Zipper-interacting protein kinase (ZIPK) modulates canonical Wnt\/beta-catenin signaling through interaction with Nemo-like kinase and T-cell factor 4 (NLK\/TCF4). J Biol Chem. 2011;286:19170\u20137.","journal-title":"J Biol Chem"},{"key":"143_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nature05610","volume":"446","author":"C Greenman","year":"2007","unstructured":"Greenman C, Stephens P, Smith R, Dalgliesh GL, Hunter C, Bignell G, et al. Patterns of somatic mutation in human cancer genomes. Nature. 2007;446:153\u20138.","journal-title":"Nature"},{"key":"143_CR35","doi-asserted-by":"publisher","first-page":"3152","DOI":"10.1158\/0008-5472.CAN-10-3543","volume":"71","author":"J Brognard","year":"2011","unstructured":"Brognard J, Zhang YW, Puto LA, Hunter T. Cancer-associated loss-of-function mutations implicate DAPK3 as a tumor-suppressing kinase. Cancer Res. 2011;71:3152\u201361.","journal-title":"Cancer Res"},{"key":"143_CR36","doi-asserted-by":"publisher","first-page":"5801","DOI":"10.1158\/1078-0432.CCR-11-1133","volume":"17","author":"XL Tan","year":"2011","unstructured":"Tan XL, Moyer AM, Fridley BL, Schaid DJ, Niu N, Batzler AJ, et al. Genetic variation predicting cisplatin cytotoxicity associated with overall survival in lung cancer patients receiving platinumbased chemotherapy. Clin Cancer Res. 2011;17:5801\u201311.","journal-title":"Clin Cancer Res"},{"key":"143_CR37","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1002\/ijc.24164","volume":"124","author":"J Bi","year":"2009","unstructured":"Bi J, Lau SH, Hu L, Rao HL, Liu HB, Zhan WH, et al. Downregulation of ZIP kinase is associated with tumor invasion, metastasis and poor prognosis in gastric cancer. Int J Cancer. 2009;124:1587\u201393.","journal-title":"Int J Cancer"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-015-0143-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13048-015-0143-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-015-0143-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-015-0143-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T10:03:29Z","timestamp":1630577009000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-015-0143-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,9]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["143"],"URL":"https:\/\/doi.org\/10.1186\/s13048-015-0143-5","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,9]]},"assertion":[{"value":"27 November 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 March 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"23"}}